Peoples Financial Services Corp. Organon & Co. Transaction History

Peoples Financial Services Corp.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 11, 2023	SELL	$19.27 - $24.63 $6,166 - $7,881	-320 Reduced 61.19%	203 $4,000
Q4 2022 Jan 12, 2023	SELL	$23.31 - $28.61 $4,662 - $5,722	-200 Reduced 27.66%	523 $0
Q3 2022 Oct 07, 2022	SELL	$23.4 - $34.25 $1,123 - $1,644	-48 Reduced 6.23%	723 $17,000
Q1 2022 Apr 15, 2022	SELL	$30.45 - $39.36 $1,522 - $1,968	-50 Reduced 6.09%	771 $27,000
Q4 2021 Jan 19, 2022	SELL	$28.67 - $37.13 $28,670 - $37,130	-1,000 Reduced 54.91%	821 $25,000
Q3 2021 Oct 15, 2021	SELL	$28.63 - $35.64 $24,135 - $30,044	-843 Reduced 31.64%	1,821 $60,000
Q2 2021 Jul 14, 2021	BUY	$28.45 - $38.0 $75,790 - $101,232	2,664 New	2,664 $80,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Peoples Financial Services Corp., based on Form 13F filings with the SEC.

Stay updated on Peoples Financial Services Corp. with notifications on news.